CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+6.97%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$4.16B
AUM Growth
+$312M
(+8.1%)
Cap. Flow
+$53.4M
Cap. Flow
% of AUM
1.28%
Top 10 Holdings %
Top 10 Hldgs %
18.39%
Holding
705
New
49
Increased
376
Reduced
176
Closed
46
Top Buys
| 1 |
Canadian National Railway
CNI
|
+$31.2M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$24.4M |
| 3 |
JNPR
Juniper Networks
JNPR
|
+$23.9M |
| 4 |
AbbVie
ABBV
|
+$23.8M |
| 5 |
Texas Instruments
TXN
|
+$21.8M |
Top Sells
| 1 |
Procter & Gamble
PG
|
+$27.8M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$22M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$19.1M |
| 4 |
Intel
INTC
|
+$16.8M |
| 5 |
CBRE Group
CBRE
|
+$15.6M |
Sector Composition
| 1 | Healthcare | 25.52% |
| 2 | Financials | 12.75% |
| 3 | Technology | 11.85% |
| 4 | Communication Services | 9.9% |
| 5 | Consumer Staples | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Southern Company
SO
$101B
| $2.47M | 0.06% |
48,178
+12,306
| +34% | +$631K |
|
302
Telus
TU
$25B
| $2.44M | 0.06% |
148,200
-4,710
| -3% | -$77.6K |
|
303
CytomX Therapeutics
CTMX
$351M
| $2.43M | 0.06% |
155,000
+88,000
| +131% | +$1.38M |
|
304
American Electric Power
AEP
$58B
| $2.42M | 0.06% |
37,710
+6,665
| +21% | +$428K |
|
305
TC Energy
TRP
$54.1B
| $2.42M | 0.06% |
50,991
-3,953
| -7% | -$187K |
|
306
Bio-Techne
TECH
$8.38B
| $2.41M | 0.06% |
88,000
-8,000
| -8% | -$219K |
|
|
ININ
307
DELISTED
Interactive Intelligence Group, inc.
ININ
| $2.41M | 0.06% |
+40,000
| New | +$2.41M |
|
|
JUNO
308
DELISTED
Juno Therapeutics, Inc.
JUNO
| $2.4M | 0.06% |
+80,000
| New | +$2.4M |
|
|
PXD
309
DELISTED
Pioneer Natural Resource Co.
PXD
| $2.38M | 0.06% |
12,810
+4,860
| +61% | +$902K |
|
310
Paychex
PAYX
$48.5B
| $2.38M | 0.06% |
41,057
-56,153
| -58% | -$3.25M |
|
|
BLUE
311
DELISTED
bluebird bio
BLUE
| $2.37M | 0.06% |
2,702
-695
| -20% | -$610K |
|
312
Edwards Lifesciences
EW
$46.9B
| $2.36M | 0.06% |
58,719
-9,837
| -14% | -$395K |
|
313
Teva Pharmaceuticals
TEVA
$22.6B
| $2.35M | 0.06% |
51,133
-8,066
| -14% | -$371K |
|
314
Bank of New York Mellon
BK
$74.6B
| $2.34M | 0.06% |
58,754
-89,752
| -60% | -$3.58M |
|
315
Qorvo
QRVO
$8.53B
| $2.34M | 0.06% |
42,041
-138,770
| -77% | -$7.73M |
|
316
Cardinal Health
CAH
$36.1B
| $2.32M | 0.06% |
29,867
-2,623
| -8% | -$204K |
|
317
Canadian Natural Resources
CNQ
$64.4B
| $2.32M | 0.06% |
148,411
-104
| -0.1% | -$1.63K |
|
318
Sysco
SYY
$38.7B
| $2.3M | 0.06% |
46,919
+5,516
| +13% | +$270K |
|
|
GHDX
319
DELISTED
Genomic Health, Inc.
GHDX
| $2.29M | 0.06% |
79,000
+16,000
| +25% | +$463K |
|
320
Brookfield
BN
$99.8B
| $2.28M | 0.05% |
121,512
-576,789
| -83% | -$10.8M |
|
321
Range Resources
RRC
$8.18B
| $2.27M | 0.05% |
58,604
+12,125
| +26% | +$470K |
|
|
MZOR
322
DELISTED
Mazor Robotics Ltd.
MZOR
| $2.26M | 0.05% |
87,500
+27,500
| +46% | +$712K |
|
323
S&P Global
SPGI
$167B
| $2.24M | 0.05% |
17,690
+2,570
| +17% | +$325K |
|
324
Becton Dickinson
BDX
$54.8B
| $2.23M | 0.05% |
12,740
+4,089
| +47% | +$717K |
|
|
ISEE
325
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $2.19M | 0.05% |
47,500
-34,500
| -42% | -$1.59M |
|